Nilo Therapeutics is an early-stage biotech company developing innovative therapies for autoimmune and inflammatory diseases. The team combines diverse expertise to modulate immune responses through neural circuit activation. Committed to advancing human health, Nilo focuses on discovering and translating novel biology into transformative treatments. The company values collaboration and entrepreneurial spirit, providing an environment for motivated individuals to contribute to groundbreaking research at the intersection of neuroscience and immunology.